A Study of SHR-A1811 and Fulvestrant, With or Without HS-10352, in Locally Advanced or Metastatic Breast Cancer Patients

NCT06788197 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

52

Enrollment

OTHER_GOV

Sponsor class

Conditions

Breast Cancer
Locally Advanced or Metastatic Breast Cancer

Interventions

DRUG: SHR-A1811+ Fulvestrant
DRUG: SHR-A1811+ Fulvestrant+HS-10352

Sponsor

Henan Cancer Hospital